These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34908008)

  • 21. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
    Niebel D; Fröhlich A; Zarbl R; Fietz S; de Vos L; Vogt TJ; Dietrich J; Sirokay J; Kuster P; Saavedra G; Ramírez Valladolid S; Hoffmann F; Strieth S; Landsberg J; Dietrich D
    Clin Epigenetics; 2022 Apr; 14(1):50. PubMed ID: 35410311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer.
    Mehdi AM; Zhou C; Turrell G; Walpole E; Porceddu S; Frazer IH; Chandra J
    Cancer Gene Ther; 2023 Apr; 30(4):629-640. PubMed ID: 36575316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
    Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
    Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
    Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.
    Chuang YH; Lin CY; Lee JC; Lee CH; Liu CL; Huang SH; Lee JY; Lai WS; Yang JM
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutation signatures in head and neck squamous cell carcinoma : Pathogenesis and therapeutic potential].
    Plath M; Hess J; Zaoui K
    HNO; 2020 Dec; 68(12):922-926. PubMed ID: 33044581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an 8 HPV-related RNA signature as a novel prognostic biomarker for squamous cell carcinoma of the head and neck.
    Mei Z; Zhengdong L; Shupeng L; Xin Z; Lei W; Wang C
    Medicine (Baltimore); 2024 Feb; 103(6):e36448. PubMed ID: 38335428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes.
    Qin T; Li S; Henry LE; Chou E; Cavalcante RG; Garb BF; D'Silva NJ; Rozek LS; Sartor MA
    Cancer Res Commun; 2023 Aug; 3(8):1701-1715. PubMed ID: 37654626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
    Dlamini Z; Alaouna M; Mbatha S; Bhayat A; Mabongo M; Chatziioannou A; Hull R
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma.
    He L; Ren D; Lv G; Mao B; Wu L; Liu X; Gong L; Liu P
    Cancer Med; 2023 Jan; 12(1):852-861. PubMed ID: 35621268
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
    Zhang HZ; Shan CG; Huang AP; Wang JM
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.
    Tawk B; Wirkner U; Schwager C; Rein K; Zaoui K; Federspil PA; Adeberg S; Linge A; Ganswindt U; Hess J; Unger K; Tinhofer I; Budach V; Lohaus F; Krause M; Guberina M; Stuschke M; Balermpas P; Rödel C; Grosu AL; Schäfer H; Zips D; Combs SE; Pigorsch S; Zitzelsberger H; Baumeister P; Kirchner T; Bewerunge-Hudler M; Weichert W; Hess J; Herpel E; Belka C; Baumann M; Debus J; Abdollahi A;
    Int J Cancer; 2022 Feb; 150(4):603-616. PubMed ID: 34648658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Klümper N; Ralser DJ; Bawden EG; Landsberg J; Zarbl R; Kristiansen G; Toma M; Ritter M; Hölzel M; Ellinger J; Dietrich D
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.
    Casarotto M; Lupato V; Giurato G; Guerrieri R; Sulfaro S; Salvati A; D'Angelo E; Furlan C; Menegaldo A; Baboci L; Montico B; Turturici I; Dolcetti R; Romeo S; Baggio V; Corrado S; Businello G; Guido M; Weisz A; Giacomarra V; Franchin G; Steffan A; Sigalotti L; Vaccher E; Boscolo-Rizzo P; Jerry P; Fanetti G; Fratta E
    Clin Epigenetics; 2022 Dec; 14(1):171. PubMed ID: 36503584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.